Globe Life Inc. (GL) Stock: Price, Forecast & Analyst Target
Globe Life Inc. (GL) — MoonshotScore 74/100 (Strong band), calculated Nov 18, 2026. Price $153.59 (-1.01%), as of the Nov 19, 2026 trading session; market cap $11.6B. Expected results Feb 3, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 0.67× (cash as of Sep 30, 2026) · expected results Feb 3, 2027
Globe Life Inc. · GL · NYSE · Financial Services · Insurance - Life
Research dated 2026-09-13: Globe Life sells life insurance, supplemental health coverage and annuities to households across the lower-middle and middle-income market, with life insurance providing the larger reported revenue base. Its durability rests on converting premium growth into underwriting profit and cash generation after temporary benefits from assumption updates fade.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Globe Life (GL)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, a strong balance sheet and durable growth, with no real weak spot — fairly priced, so not a bargain entry. Business Quality: Solid; Financial Safety: Sound; Valuation: Fair; Growth Durability: Growing; Momentum: Slipping.
- EPS beat 1 of the last 8 reports
- expected results Feb 3, 2027
- Altman Z 1.96 · Piotroski F 8
Helping: business quality, balance-sheet strength, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 81 | Exceptional | |
| 78 | Strong | |
| 78 | Strong | |
| 74 | Strong | |
| 74 | Strong | |
| 74 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $153.59 | |
| Change on the day | -1.01% | |
| 52-week range | $129.21–$191.55 | |
| Market capitalisation | $11.6B | — |
| Price / earnings (trailing) | 10.38 | |
| Shares traded on the day | 1.04M | |
| Beta (volatility vs the S&P 500) | 0.46 | |
| Dividends per share (last 12 months) | $1.26 | |
| Dividend yield (last 12 months) | 0.80% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For the full year,, we expect total premium revenue growth to be around 6.5%.
Frank Martin Svoboda · Statement from
For the full year, we expect life premium revenue to grow between 2.5% to 2.75%, driven by strong premium growth in our American Income and Liberty National divisions.
Frank Martin Svoboda · Statement from
How to read these dates
Events are in date order; the spacing is not a duration scale. A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for Globe Life (GL): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 20, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Globe Life (GL), and what does it report?
Short answer · as of
Globe Life is primarily a household protection insurer, not an asset manager that happens to own insurance operations. Customers buy life protection, Medicare supplements, critical-illness and accident coverage, while annuities add a savings-oriented product line.
Research dated 2026-09-13.
Reported revenue combines insurance operations with the economics of a substantial investment portfolio. Life contributes considerably more segment revenue than health, while underwriting margins reveal how much premium remains after the associated insurance costs.
What do the latest results show for Globe Life (GL)?
Research dated 2026-09-13.
The latest results extended the upward revenue trend and produced higher net income and diluted earnings than the preceding period. Revenue exceeded consensus, yet earnings fell short, showing that premium and investment-related growth did not translate cleanly into the expected bottom line.
Operating cash flow remained positive but retreated from the preceding period. Management separately expects continued premium growth and says assumption updates should lift life underwriting margin temporarily, while health underwriting remains within its stated outlook range.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $1.60B Sep 30, 2026
- Latest quarter · SG&A
- $422.79M Sep 30, 2026
- Latest quarter · FMP standardized operating result
- $479.05M Sep 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | $1.60B | Not available | $422.79M | $479.05M |
| Jun 30, 2026 | $1.60B | Not available | −$174.43M | −$629.62M |
| Mar 31, 2026 | $1.56B | Not available | $401.90M | $368.13M |
| Dec 31, 2025 | $1.52B | Not available | $92.00M | $356.26M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $1.60B Oct 21, 2026
- Latest report · revenue estimate
- $1.56B Oct 21, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 21, 2026
- Latest report · EPS vs estimate
- Below estimate Oct 21, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 21, 2026 | $1.60B | $1.56B | $4.8400 | $4.9000 |
| Jul 22, 2026 | $1.60B | $1.59B | $3.6100 | $3.6700 |
| Apr 22, 2026 | $1.56B | $1.56B | $3.4300 | $3.4700 |
| Feb 4, 2026 | $1.52B | $1.53B | $3.3900 | $3.4400 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $1.51B | $388M | $4.71 (diluted) |
| Q4 FY2025 | $1.52B | $266M | $3.29 (diluted) |
| Q1 FY2026 | $1.56B | $271M | $3.45 (diluted) |
| Q2 FY2026 | $1.60B | $288M | $3.65 (diluted) |
What are the financial strengths and risks for Globe Life (GL)?
Short answer
Cash and short-term investments were $17.23B at the Sep 30, 2026 balance-sheet date. Operating cash flow was $325.76M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Globe Life has generated positive operating cash flow throughout the reported series, generally with modest capital spending. That supports recurring distributions without requiring the company to rely solely on balance-sheet liquidity.
The large investment balance must be read alongside substantial insurance liabilities; it is not equivalent to freely deployable cash. Debt is meaningful, and a recently disclosed credit agreement adds another reason to monitor financing structure, while weaker underwriting or adverse assumption changes could pressure earnings even if premium revenue keeps rising.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $325.76M Sep 30, 2026
- Previous quarter · operating cash flow
- $314.06M Jun 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Sep 30, 2026 | $325.76M | −$14.94M |
| Jun 30, 2026 | $314.06M | −$16.49M |
| Mar 31, 2026 | $420.94M | −$24.91M |
| Dec 31, 2025 | $350.60M | −$20.50M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at Globe Life (GL)?
Short answer · as of
The next earnings report is expected on Feb 3, 2027.
Research dated 2026-09-13.
At the scheduled earnings release, compare premium growth with the stated outlook and separate recurring life underwriting performance from the anticipated benefit of assumption updates. Health underwriting margin also deserves attention because the smaller health segment is expected to absorb a developing business that has not yet reached management’s target scale.
Consensus pairs lower sequential revenue with a pronounced earnings step-up. Meeting that combination would require stronger profit conversion, making the relationship among reported revenue, underwriting margins and operating cash flow more informative than the headline earnings comparison alone.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
We anticipate life underwriting margin as a percent of premium to be between 44% to 45% for the full year 2026.
Frank Martin Svoboda ·
For the full year, we expect health premium revenues to grow by around 15% and underwriting margin to grow in the range of 4.0% to 4.5%.
Frank Martin Svoboda ·
How does Globe Life compare with its peers?
Short answer
Globe Life's score ranks 8th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Globe Life combines a life-led insurance franchise with a sizable supplemental health operation focused on households below the affluent market. That mix differs from a pure life carrier and from a health insurer centered on comprehensive medical benefits: Globe Life’s health products supplement other coverage rather than replace it.
Its investment portfolio is economically central, as with other life insurers, but segment revenue remains concentrated in life and health protection. Comparisons are therefore most useful when they account for product mix, underwriting margins and investment-backed liabilities rather than treating consolidated revenue as directly interchangeable across insurers.
| Company | Price | Market value | Score |
|---|---|---|---|
| $288.71 Nov 19, 2026 | $8.76B | 96 5-pillar Nov 18, 2026 | |
| $20.47 Nov 19, 2026 | $3.77B | 96 5-pillar Nov 18, 2026 | |
| $315.92 Nov 19, 2026 | $15.5B | 95 5-pillar Nov 18, 2026 | |
| $156.87 Nov 19, 2026 | $13.0B | 94 5-pillar Nov 18, 2026 | |
| $97.60 Nov 19, 2026 | $61.3B | 88 5-pillar Nov 18, 2026 | |
| $120.30 Nov 19, 2026 | $41.3B | 85 5-pillar Nov 18, 2026 | |
| $55.02 Nov 19, 2026 | $5.03B | 78 5-pillar Nov 18, 2026 | |
| Globe Life (GL) — this page | $153.59 | $11.6B | 74 |
| $41.05 Nov 19, 2026 | $7.82B | 61 5-pillar Nov 18, 2026 | |
| $77.04 Nov 19, 2026 | $11.9B | 56 5-pillar Nov 18, 2026 | |
| $8.28 Nov 19, 2026 | $12.1B | 53 5-pillar Nov 18, 2026 | |
| $24.78 Nov 19, 2026 | $30.2B | 48 5-pillar Nov 18, 2026 | |
| $14.68 Nov 19, 2026 | $2.49B | 31 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $165.00 – $215.00
- Consensus target
- $184.75
- Median target
- $181.00
Consensus record · Captured .
Measured against a quoted price of $153.59 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 11, 2026
- Transactions
- 67
- Identified insiders
- 9
- Purchases
- 0
- Sales
- 33
- Other transactions
- 34
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 81.6% Period end Sep 30, 2026
- Previous quarter · ownership
- 83.7% Prior to period end Sep 30, 2026
- Reporting holders
- 701 Period end Sep 30, 2026
- Previous quarter · holders
- 719 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 5,506,854 |
| Vanguard Capital Management LLC | 5,030,574 |
| Invesco Ltd. | 5,020,088 |
| Vanguard Portfolio Management LLC | 4,128,920 |
| State Street Corp | 3,517,006 |
Tracked investors
Which of the 16 named investors we follow held GL in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0.07% | $16.74M | Added +52.8% shares |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Globe Life (GL)?
What Investors Ask About Globe Life (GL) — Financial Services
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Is Globe Life mainly a life insurer or a supplemental health insurer?
Life insurance is the larger reported segment, while supplemental health remains a substantial contributor. Annuities and investments broaden the model but do not change its life-led operating profile.
Why is Globe Life’s investment portfolio so large?
Investment assets are integral to the economics of a life insurer carrying long-duration policy obligations. They should be considered against Globe Life’s insurance liabilities rather than treated as idle corporate cash.
Why can Globe Life revenue beat expectations while earnings miss?
The latest release showed that exact split. Underwriting margins and assumption updates can alter profit conversion independently of the consolidated revenue comparison.
What could lift Globe Life’s life underwriting margin temporarily?
Management expects assumption updates to provide a temporary lift. The more durable signal will be the margin retained after that effect passes while premium revenue continues to develop.
What is the GL stock price today?
The last price recorded for Globe Life Inc. (GL), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the GL price target?
The analyst consensus price target for Globe Life Inc. (GL), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 78 figures on this page — 2 from SEC filings and earnings calls, 66 from Financial Modeling Prep (FMP), 4 with no recorded source, 5 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-13), by section of the research
ETFs that hold GL
Funds in our ETF coverage that list GL among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| Invesco S&P 500 Equal Weight Financials ETF (RSPF) | 1.47% |